The KEGG pathway enrichment analysis results revealed that the main phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway, metabolic pathways, cancer pathways, proteoglycans in cancer, chemical carcinogenesis-receptor activation pathway, and chemical carcinogenesis-ROS pathway were among Huangkui targets in the treatment of IMN. Here, AKT1 is linked to cancer.